These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16615544)

  • 21. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
    Bachmann AE; Giraudo Conesa LC; Braun M
    Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
    [No Abstract]   [Full Text] [Related]  

  • 22. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
    Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
    Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C; Agawa H; Sairenji T; Inoue Y
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [IgA antibodies against Epstein-Barr virus capsid antigen].
    Chalupa P; Slesinger P; Krchnáková A; Prásek J
    Cas Lek Cesk; 1992 Sep; 131(17):526-9. PubMed ID: 1330312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Seroprevalence of Epstein Barr virus infection in a healthy population of Santiago de Chile].
    Ferrés M; Prado P; Ovalle J; Fuentes R; Villarroel L; Ferreccio C; Vial P
    Rev Med Chil; 1995 Dec; 123(12):1447-52. PubMed ID: 8733260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Epstein-Barr virus infections in children.
    Sumaya CV
    Pediatrics; 1977 Jan; 59(1):16-21. PubMed ID: 190581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serological diagnosis of infectious mononucleosis caused by Epstein-Barr virus].
    de Ory F
    Enferm Infecc Microbiol Clin; 1991 Jan; 9(1):63-4. PubMed ID: 1851444
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of immunity to Epstein-Barr virus in Malaysian children.
    Yadav MS; Malliga N; Ablashi DV
    Microbiologica; 1987 Jan; 10(1):29-35. PubMed ID: 3033449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
    Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M
    Am J Epidemiol; 2007 Jan; 165(2):134-7. PubMed ID: 17005627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
    Fark AR
    J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of immunofluorescence assay and multiplexed microparticle-based immunoassay for detecting Epstein-Barr virus viral capsid antigen antibodies.
    Zeytinoglu A; Altuglu I; Karatas E; Yazan Sertoz R
    J Virol Methods; 2008 Mar; 148(1-2):300-2. PubMed ID: 18215427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
    Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
    J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
    Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
    J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus (EBV) early-antigen antibodies and EBV DNA load in blood, in posttransplantation lymphoproliferative disease.
    Leruez-Ville M; Talbotec C; Iserin F; Salomon R; Lacaille F; Rouzioux C
    J Infect Dis; 2004 Oct; 190(8):1524-5; author reply 1525-6. PubMed ID: 15378447
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
    Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
    J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment.
    Condon LM; Cederberg LE; Rabinovitch MD; Liebo RV; Go JC; Delaney AS; Schmeling DO; Thomas W; Balfour HH
    Clin Infect Dis; 2014 Aug; 59(4):501-8. PubMed ID: 24820696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of Hodgkin's lymphoma after infectious mononucleosis.
    Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang JS; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
    N Engl J Med; 2003 Oct; 349(14):1324-32. PubMed ID: 14523140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.